Tamarra James-Todd, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phthalic Acids | 27 | 2024 | 478 | 7.210 |
Why?
|
Environmental Pollutants | 33 | 2024 | 1277 | 7.040 |
Why?
|
Endocrine Disruptors | 11 | 2024 | 264 | 4.440 |
Why?
|
Hair Preparations | 7 | 2021 | 32 | 3.190 |
Why?
|
Fluorocarbons | 8 | 2024 | 492 | 2.970 |
Why?
|
Diabetes, Gestational | 14 | 2022 | 1248 | 2.810 |
Why?
|
Cosmetics | 7 | 2023 | 102 | 2.760 |
Why?
|
Environmental Exposure | 21 | 2024 | 4485 | 2.250 |
Why?
|
Maternal Exposure | 17 | 2024 | 1067 | 2.150 |
Why?
|
Pregnancy Trimester, First | 13 | 2024 | 907 | 1.930 |
Why?
|
Pregnancy | 73 | 2024 | 29890 | 1.900 |
Why?
|
Pregnancy in Diabetics | 6 | 2021 | 197 | 1.710 |
Why?
|
Blood Glucose | 19 | 2024 | 6391 | 1.690 |
Why?
|
Premature Birth | 10 | 2023 | 1782 | 1.650 |
Why?
|
Glucose Intolerance | 4 | 2022 | 575 | 1.630 |
Why?
|
Pregnancy Trimester, Second | 10 | 2024 | 731 | 1.610 |
Why?
|
Pregnancy Complications | 10 | 2024 | 2947 | 1.470 |
Why?
|
Halogenated Diphenyl Ethers | 6 | 2024 | 83 | 1.410 |
Why?
|
Birth Weight | 15 | 2023 | 2103 | 1.390 |
Why?
|
Pregnancy Outcome | 9 | 2024 | 2922 | 1.290 |
Why?
|
Diethylhexyl Phthalate | 4 | 2022 | 83 | 1.290 |
Why?
|
Environmental Health | 3 | 2024 | 290 | 1.110 |
Why?
|
Alkanesulfonic Acids | 4 | 2024 | 201 | 1.100 |
Why?
|
Menarche | 3 | 2018 | 532 | 1.070 |
Why?
|
Perimenopause | 3 | 2024 | 142 | 1.060 |
Why?
|
Postpartum Period | 6 | 2024 | 1175 | 1.050 |
Why?
|
Body Mass Index | 16 | 2024 | 12953 | 0.970 |
Why?
|
Caprylates | 3 | 2020 | 115 | 0.960 |
Why?
|
Benzophenones | 2 | 2024 | 58 | 0.920 |
Why?
|
Hyperglycemia | 3 | 2019 | 1376 | 0.880 |
Why?
|
Phenols | 4 | 2022 | 517 | 0.850 |
Why?
|
Hair | 2 | 2023 | 498 | 0.810 |
Why?
|
Oils | 1 | 2021 | 56 | 0.750 |
Why?
|
Obesity | 9 | 2024 | 12947 | 0.700 |
Why?
|
Boston | 12 | 2024 | 9327 | 0.690 |
Why?
|
Female | 102 | 2024 | 392705 | 0.690 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2022 | 3415 | 0.690 |
Why?
|
Bayes Theorem | 10 | 2024 | 2330 | 0.680 |
Why?
|
Climate | 1 | 2020 | 147 | 0.680 |
Why?
|
Fertility | 2 | 2024 | 771 | 0.660 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2022 | 518 | 0.630 |
Why?
|
Health Status Disparities | 4 | 2024 | 1853 | 0.630 |
Why?
|
Fertility Agents | 1 | 2018 | 11 | 0.630 |
Why?
|
Health Literacy | 1 | 2024 | 444 | 0.620 |
Why?
|
Pregnancy Trimesters | 2 | 2017 | 197 | 0.610 |
Why?
|
Trace Elements | 1 | 2019 | 195 | 0.610 |
Why?
|
Benzhydryl Compounds | 3 | 2022 | 916 | 0.580 |
Why?
|
Cadmium | 1 | 2018 | 214 | 0.570 |
Why?
|
Adult | 62 | 2024 | 221210 | 0.570 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2021 | 2518 | 0.560 |
Why?
|
Copper | 1 | 2019 | 369 | 0.560 |
Why?
|
Fathers | 1 | 2019 | 376 | 0.540 |
Why?
|
Infant, Newborn | 23 | 2024 | 26202 | 0.530 |
Why?
|
Infertility | 2 | 2020 | 654 | 0.520 |
Why?
|
Flame Retardants | 3 | 2021 | 96 | 0.520 |
Why?
|
Young Adult | 30 | 2024 | 59260 | 0.510 |
Why?
|
Humans | 111 | 2024 | 761596 | 0.500 |
Why?
|
Emigrants and Immigrants | 2 | 2022 | 543 | 0.500 |
Why?
|
Pre-Eclampsia | 3 | 2024 | 1231 | 0.500 |
Why?
|
Prospective Studies | 23 | 2024 | 54423 | 0.460 |
Why?
|
Nutrition Surveys | 8 | 2022 | 1733 | 0.460 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2020 | 12149 | 0.420 |
Why?
|
Gestational Age | 3 | 2021 | 3577 | 0.410 |
Why?
|
Fetus | 1 | 2020 | 1863 | 0.410 |
Why?
|
Air Pollution | 2 | 2023 | 2359 | 0.400 |
Why?
|
Linear Models | 8 | 2022 | 5872 | 0.400 |
Why?
|
Massachusetts | 6 | 2024 | 8833 | 0.400 |
Why?
|
Body Weight | 3 | 2017 | 4618 | 0.390 |
Why?
|
Glucose | 2 | 2021 | 4347 | 0.380 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 389 | 0.380 |
Why?
|
Parabens | 3 | 2022 | 114 | 0.370 |
Why?
|
Pregnancy Trimester, Third | 3 | 2024 | 583 | 0.370 |
Why?
|
Hypoglycemia | 1 | 2017 | 883 | 0.350 |
Why?
|
Air Pollution, Indoor | 3 | 2021 | 901 | 0.330 |
Why?
|
Prenatal Care | 5 | 2021 | 1141 | 0.330 |
Why?
|
Blood Pressure | 2 | 2024 | 8481 | 0.320 |
Why?
|
Cohort Studies | 16 | 2024 | 41495 | 0.320 |
Why?
|
Depression | 4 | 2017 | 8126 | 0.320 |
Why?
|
Hot Flashes | 2 | 2022 | 330 | 0.320 |
Why?
|
Menstruation | 1 | 2010 | 307 | 0.320 |
Why?
|
Glucose Tolerance Test | 4 | 2024 | 1178 | 0.320 |
Why?
|
Age Factors | 4 | 2020 | 18399 | 0.320 |
Why?
|
Metals | 2 | 2024 | 719 | 0.310 |
Why?
|
Food Supply | 2 | 2024 | 544 | 0.310 |
Why?
|
Overweight | 3 | 2020 | 2417 | 0.300 |
Why?
|
Infant, Premature | 1 | 2017 | 2107 | 0.300 |
Why?
|
Women's Health | 4 | 2024 | 2065 | 0.300 |
Why?
|
New York City | 3 | 2018 | 731 | 0.300 |
Why?
|
Pregnant Women | 4 | 2022 | 567 | 0.290 |
Why?
|
Weight Gain | 2 | 2023 | 2348 | 0.290 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14608 | 0.270 |
Why?
|
Exercise | 2 | 2020 | 5890 | 0.270 |
Why?
|
Sigmoidoscopy | 1 | 2006 | 151 | 0.250 |
Why?
|
United States | 15 | 2024 | 72340 | 0.250 |
Why?
|
Logistic Models | 10 | 2019 | 13255 | 0.250 |
Why?
|
New York | 2 | 2021 | 874 | 0.240 |
Why?
|
Fetal Development | 2 | 2022 | 769 | 0.240 |
Why?
|
Odds Ratio | 6 | 2022 | 9647 | 0.230 |
Why?
|
Maternal Age | 2 | 2019 | 809 | 0.220 |
Why?
|
Soaps | 2 | 2023 | 29 | 0.220 |
Why?
|
Environmental Monitoring | 5 | 2021 | 1460 | 0.220 |
Why?
|
Middle Aged | 21 | 2024 | 220921 | 0.210 |
Why?
|
Child | 16 | 2024 | 80158 | 0.210 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 24 | 0.200 |
Why?
|
Phenanthrenes | 1 | 2022 | 66 | 0.200 |
Why?
|
Epidemiologic Studies | 1 | 2024 | 675 | 0.190 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2024 | 2151 | 0.180 |
Why?
|
Menopause | 2 | 2021 | 1646 | 0.180 |
Why?
|
Risk Factors | 14 | 2024 | 74213 | 0.180 |
Why?
|
Estrogens | 2 | 2021 | 1522 | 0.180 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12059 | 0.170 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 702 | 0.170 |
Why?
|
Cross-Sectional Studies | 9 | 2022 | 26129 | 0.170 |
Why?
|
Food Contamination | 1 | 2021 | 191 | 0.170 |
Why?
|
Progesterone | 1 | 2024 | 742 | 0.170 |
Why?
|
Molybdenum | 1 | 2019 | 46 | 0.170 |
Why?
|
Humidity | 1 | 2020 | 205 | 0.170 |
Why?
|
North America | 1 | 2023 | 1276 | 0.170 |
Why?
|
Acculturation | 1 | 2020 | 178 | 0.160 |
Why?
|
Adolescent | 17 | 2024 | 88326 | 0.160 |
Why?
|
Paternal Exposure | 1 | 2019 | 96 | 0.160 |
Why?
|
Social Justice | 1 | 2023 | 478 | 0.160 |
Why?
|
Pilot Projects | 4 | 2023 | 8633 | 0.150 |
Why?
|
Infertility, Female | 1 | 2024 | 760 | 0.150 |
Why?
|
Commerce | 1 | 2023 | 607 | 0.150 |
Why?
|
beta Carotene | 1 | 2019 | 523 | 0.150 |
Why?
|
Analgesia, Obstetrical | 1 | 2019 | 169 | 0.150 |
Why?
|
Cotinine | 1 | 2018 | 206 | 0.150 |
Why?
|
Colonoscopy | 1 | 2006 | 1394 | 0.150 |
Why?
|
Puerperal Disorders | 1 | 2020 | 300 | 0.140 |
Why?
|
Polychlorinated Biphenyls | 1 | 2019 | 236 | 0.140 |
Why?
|
Insulin | 4 | 2022 | 6597 | 0.140 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.140 |
Why?
|
Obstetric Labor Complications | 1 | 2019 | 236 | 0.140 |
Why?
|
Parity | 1 | 2020 | 927 | 0.140 |
Why?
|
Estradiol | 1 | 2024 | 1937 | 0.140 |
Why?
|
Maternal-Fetal Exchange | 1 | 2019 | 461 | 0.140 |
Why?
|
Selenium | 1 | 2019 | 417 | 0.140 |
Why?
|
Analgesia, Epidural | 1 | 2019 | 332 | 0.130 |
Why?
|
Testosterone | 2 | 2024 | 2472 | 0.130 |
Why?
|
Vitamins | 1 | 2024 | 1635 | 0.130 |
Why?
|
Age of Onset | 2 | 2014 | 3306 | 0.130 |
Why?
|
Zinc | 1 | 2019 | 690 | 0.120 |
Why?
|
Risk | 3 | 2018 | 9610 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2016 | 6228 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2016 | 1541 | 0.120 |
Why?
|
Male | 19 | 2024 | 360846 | 0.120 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 3085 | 0.120 |
Why?
|
China | 1 | 2020 | 2374 | 0.120 |
Why?
|
Infant, Low Birth Weight | 2 | 2023 | 870 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1352 | 0.120 |
Why?
|
Triglycerides | 1 | 2022 | 2461 | 0.110 |
Why?
|
Self Report | 4 | 2019 | 3725 | 0.110 |
Why?
|
Seasons | 1 | 2020 | 1520 | 0.110 |
Why?
|
Temperature | 1 | 2020 | 2226 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 5841 | 0.110 |
Why?
|
Sex Factors | 2 | 2020 | 10554 | 0.110 |
Why?
|
Interviews as Topic | 3 | 2012 | 2696 | 0.110 |
Why?
|
Insulin Infusion Systems | 1 | 2014 | 217 | 0.110 |
Why?
|
Mothers | 1 | 2023 | 2198 | 0.110 |
Why?
|
Mexican Americans | 1 | 2014 | 167 | 0.110 |
Why?
|
Stillbirth | 1 | 2016 | 368 | 0.110 |
Why?
|
Cholesterol | 1 | 2022 | 2905 | 0.100 |
Why?
|
Pregnancy Proteins | 1 | 2013 | 222 | 0.100 |
Why?
|
Particulate Matter | 2 | 2022 | 2605 | 0.100 |
Why?
|
Public Health | 2 | 2023 | 2669 | 0.100 |
Why?
|
Societies, Medical | 1 | 2014 | 3905 | 0.100 |
Why?
|
Erythrocytes | 1 | 2021 | 2413 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1618 | 0.100 |
Why?
|
Language | 1 | 2020 | 1543 | 0.090 |
Why?
|
Social Class | 3 | 2019 | 2004 | 0.090 |
Why?
|
Infant, Small for Gestational Age | 1 | 2013 | 461 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1886 | 0.090 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 846 | 0.090 |
Why?
|
Sulfonamides | 1 | 2020 | 1979 | 0.090 |
Why?
|
Aged | 10 | 2019 | 169310 | 0.090 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 558 | 0.090 |
Why?
|
Infant | 7 | 2024 | 36193 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39106 | 0.090 |
Why?
|
Aged, 80 and over | 6 | 2019 | 58984 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4016 | 0.080 |
Why?
|
Spouse Abuse | 1 | 2010 | 182 | 0.080 |
Why?
|
Fasting | 1 | 2015 | 1603 | 0.080 |
Why?
|
Prejudice | 1 | 2012 | 570 | 0.080 |
Why?
|
Occupations | 1 | 2010 | 515 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6345 | 0.080 |
Why?
|
Registries | 1 | 2024 | 8225 | 0.080 |
Why?
|
Dust | 2 | 2021 | 487 | 0.070 |
Why?
|
Child Abuse, Sexual | 1 | 2010 | 403 | 0.070 |
Why?
|
Air Pollutants | 1 | 2021 | 2896 | 0.070 |
Why?
|
Diet | 2 | 2024 | 8075 | 0.070 |
Why?
|
Prevalence | 4 | 2018 | 15733 | 0.070 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2010 | 294 | 0.070 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 467 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3575 | 0.070 |
Why?
|
Educational Status | 1 | 2013 | 2522 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2014 | 818 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6938 | 0.060 |
Why?
|
Computer Simulation | 1 | 2019 | 6241 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2019 | 3964 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4399 | 0.060 |
Why?
|
Osteoarthritis | 1 | 2013 | 1063 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2927 | 0.060 |
Why?
|
Occult Blood | 1 | 2006 | 198 | 0.060 |
Why?
|
Mental Health | 2 | 2024 | 3250 | 0.060 |
Why?
|
Textbooks as Topic | 1 | 2004 | 19 | 0.060 |
Why?
|
Residence Characteristics | 2 | 2024 | 2095 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7968 | 0.060 |
Why?
|
Alkanesulfonates | 1 | 2023 | 15 | 0.060 |
Why?
|
Child, Preschool | 5 | 2024 | 42232 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1277 | 0.050 |
Why?
|
Incidence | 3 | 2018 | 21355 | 0.050 |
Why?
|
Weight Loss | 1 | 2014 | 2684 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20100 | 0.050 |
Why?
|
Urban Population | 1 | 2011 | 2036 | 0.050 |
Why?
|
Dicarboxylic Acids | 1 | 2022 | 77 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 15502 | 0.050 |
Why?
|
Poverty | 2 | 2024 | 2697 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2020 | 80647 | 0.050 |
Why?
|
Plastics | 1 | 2022 | 117 | 0.050 |
Why?
|
Follicle Stimulating Hormone | 1 | 2024 | 726 | 0.050 |
Why?
|
Child Abuse | 1 | 2010 | 1077 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 9053 | 0.050 |
Why?
|
Naphthalenes | 1 | 2022 | 198 | 0.050 |
Why?
|
Hypercholesterolemia | 2 | 2018 | 1141 | 0.050 |
Why?
|
Beta Particles | 1 | 2021 | 51 | 0.050 |
Why?
|
Stress, Psychological | 2 | 2016 | 4481 | 0.050 |
Why?
|
Fluorenes | 1 | 2022 | 157 | 0.050 |
Why?
|
Epidemiology | 1 | 2004 | 279 | 0.050 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.050 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2021 | 141 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9319 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 245 | 0.050 |
Why?
|
Silicones | 1 | 2021 | 228 | 0.040 |
Why?
|
Hydroxylation | 1 | 2019 | 137 | 0.040 |
Why?
|
Esters | 1 | 2020 | 211 | 0.040 |
Why?
|
Luciferases | 1 | 2021 | 714 | 0.040 |
Why?
|
Fetal Macrosomia | 1 | 2020 | 141 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2006 | 1386 | 0.040 |
Why?
|
Breast | 1 | 2008 | 1967 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2004 | 1336 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4762 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2273 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23996 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 17354 | 0.040 |
Why?
|
Culture | 1 | 2020 | 623 | 0.030 |
Why?
|
Gonads | 1 | 2016 | 109 | 0.030 |
Why?
|
Research Design | 2 | 2024 | 6180 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 858 | 0.030 |
Why?
|
Hypertension | 3 | 2024 | 8540 | 0.030 |
Why?
|
Kuwait | 1 | 2016 | 92 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 945 | 0.030 |
Why?
|
Leiomyoma | 1 | 2019 | 636 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1757 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2024 | 1784 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2016 | 2639 | 0.030 |
Why?
|
Primary Prevention | 1 | 2021 | 1186 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2426 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39969 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2016 | 552 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2016 | 701 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2018 | 21019 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1659 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2023 | 22176 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 935 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12463 | 0.020 |
Why?
|
Bone Density | 1 | 2023 | 3551 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
Fertilization in Vitro | 1 | 2017 | 1292 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2024 | 4527 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 7828 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1188 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3801 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8466 | 0.020 |
Why?
|
Switzerland | 1 | 2004 | 324 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10508 | 0.010 |
Why?
|
Postmenopause | 1 | 2008 | 2513 | 0.010 |
Why?
|
Mammography | 1 | 2008 | 2430 | 0.010 |
Why?
|
History, 20th Century | 1 | 2004 | 2767 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15843 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168475 | 0.000 |
Why?
|